Sodium apolate

{{Short description|Vasoprotective}}

{{cs1 config|name-list-style=vanc|display-authors=6}}

{{Drugbox

| IUPAC_name =

| image = Sodium apolate.svg

| width = 150

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 25053-27-4

| ATC_prefix = C05

| ATC_suffix = BA02

| PubChem = 3270262

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 9461405D9F

| KEGG = D04825

| ChemSpiderID = none

| chemical_formula = (C2H3NaO3S)n, with n~25

| molecular_weight =

}}

Sodium apolate (INN) or lyapolate sodium (USAN) is a vasoprotective.{{cite book | vauthors = Milne GW |url=https://books.google.com/books?id=QxcoEAAAQBAJ&dq=%22Sodium+apolate%22+-com+-net&pg=PA1039 |title=Drugs: Synonyms and Properties |date=2002-02-01 |publisher=John Wiley & Sons |isbn=978-0-566-08491-1 |language=en}}

References

{{Reflist}}{{Vasoprotectives}}

Category:Organic sodium salts

Category:Vinyl polymers

Category:Sulfonates

{{cardiovascular-drug-stub}}